Skip to Main Content

Paper Details

KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapies.
Oncotarget
9
2017
Author NameAffiliation
Darragh G McArtQueen's University Belfast
Shu-Dong ZhangQueen's University Belfast
Shu-Dong ZhangBiomedical Sciences Research Institute, Ulster University
  • 1 - 3

Datasets

Release 1.2